| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 3 | |
| #2 | Australia | 2 | |
| #3 | Brazil | 2 | |
| #4 | Canada | 2 | |
| #5 | China | 2 | |
| #6 | Israel | 2 | |
| #7 | Republic of Korea | 2 | |
| #8 | WIPO (World Intellectual Property Organization) | 2 | |
| #9 | Hong Kong | 1 | |
| #10 | Mexico | 1 | |
| #11 | Russian Federation | 1 | |
| #12 | Taiwan | 1 | |
| #13 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Belanger Coralie | 17 |
| #2 | Launay Pierre | 17 |
| #3 | Souchet Herve | 8 |
| #4 | Souchet Hervé | 8 |
| #5 | Coralie Belanger | 5 |
| #6 | Pierre Launay | 5 |
| #7 | Hervé Souchet | 3 |
| #8 | Herve Souchet | 2 |
| Publication | Filing date | Title |
|---|---|---|
| EP3552631A1 | Antibody-drug conjugates and their uses for the treatment of cancer | |
| EP3325509A1 | Anti-tfr antibodies and their use in treating proliferative and inflammatory disorders |